All In MedTech

FDA Clearance Tracker · P140002

MISAGO PERIPHERAL SELF-EXPANDING STENT SYSTEM

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: May 22, 2015 (this decision)Source: openFDAMethods & limitations

PMA

Decided

May 22, 2015

Approved

Time to decision

442 days

Received Mar 6, 2014. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P140002
Device name
MISAGO PERIPHERAL SELF-EXPANDING STENT SYSTEM
Applicant location
Hatagaya
Received
Mar 6, 2014
Decided
May 22, 2015
Decision
Approved
Supplements
31 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code NIP

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE MISAGO PERIPHERAL SELF-EXPANDING STENT SYSTEM. THIS DEVICE IS INDICATED TO IMPROVE LUMINAL DIAMETER IN SYMPTOMATIC PATIENTS WITH DE NOVO OR RESTENOTIC NATIVE LESIONS OR OCCLUSIONS OF THE SUPERFICIAL FEMORAL ARTERY (SFA) AND/OR PROXIMAL POPLITEAL ARTERY WITH REFERENCE VESSEL DIAMETERS RANGING FROM 4MM TO 7MM AND LESION LENGTH UP TO 150MM.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code NIP. The earliest in FDA's data is P000033, decided Apr 3, 2002.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Terumo Medical Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.